Suturing training in Augmented Reality: gaining proficiency in suturing skills faster

por Botden, S. M. B. I., de Hingh, I. H. J. T., Jakimowicz, J. J.
Publicado 2008

Meaningful assessment method for laparoscopic suturing training in augmented reality

por Botden, Sanne M. B. I., de Hingh, I. H. J. T., Jakimowicz, J. J.
Publicado 2009

To Sleeve or NOT to Sleeve in Bariatric Surgery?

por van Rutte, P. W. J., Luyer, M. D. P., de Hingh, I. H. J. T., Nienhuijs, S. W.
Publicado 2012

Vacuum grasping as a manipulation technique for minimally invasive surgery

por Vonck, D., Goossens, R. H. M., van Eijk, D. J., de Hingh, I. H. J. T., Jakimowicz, J. J.
Publicado 2010

Role Of Ovarian Metastases In Colorectal Cancer (ROMIC): a Dutch study protocol to evaluate the effect of prophylactic salpingo-oophorectomy in postmenopausal women

por Van der Meer, R., de Hingh, I. H. J. T., Bloemen, J. G., Janssen, L., Roumen, R. M. H.
Publicado 2022

Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin

por van Oudheusden, T. R., Razenberg, L. G., van Gestel, Y. R., Creemers, G. J., Lemmens, V. E., de Hingh, I. H.
Publicado 2015

Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer

por Verheij, F. S., Bakkers, C., van Eden, W. J., Aalbers, A. G. J., Nienhuijs, S. W., Jóźwiak, K., de Hingh, I. H. J. T., Kok, N. F. M.
Publicado 2020

Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study

por Bakkers, C., Lurvink, R. J., Rijken, A., Nienhuijs, S. W., Kok, N. F., Creemers, G. J., Verhoef, C., Lemmens, V. E., van Erning, F. N., De Hingh, I. H.
Publicado 2021

Randomized clinical trial and meta-analysis of the impact of a fibrin sealant patch on pancreatic fistula after distal pancreatectomy: CPR trial

por Mungroop, T H, van der Heijde, N, Busch, O R, de Hingh, I H, Scheepers, J J, Dijkgraaf, M G, Groot Koerkamp, B, Besselink, M G, van Eijck, C H
Publicado 2021

Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice

por Razenberg, L. G. E. M., van Gestel, Y. R. B. M., de Hingh, I. H. J. T., Loosveld, O. J. L., Vreugdenhil, G., Beerepoot, L. V., Creemers, G. J., Lemmens, V. E. P. P.
Publicado 2016

Impact of time interval between multidisciplinary team meeting and intended pancreatoduodenectomy on oncological outcomes

por Steen, M. W., van Rijssen, L. B., Festen, S., Busch, O. R., Groot Koerkamp, B., van der Geest, L. G., de Hingh, I. H., van Santvoort, H. C., Besselink, M. G., Gerhards, M. F.
Publicado 2020

Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands

por Haj Mohammad, N., Bernards, N., Besselink, M. G. H., Busch, O. R., Wilmink, J. W., Creemers, G. J. M., De Hingh, I. H. J. T., Lemmens, V. E. P. P., van Laarhoven, H. W. M.
Publicado 2016

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyper...

por Sluiter, N. R., de Cuba, E. M. V., Kwakman, R., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Coupé, V. M. H., Beliën, J. A. M., Meijer, G. A., de Hingh, I. H. J. T., te Velde, E. A.
Publicado 2016

Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival

por Kwakman, R, de Cuba, E M V, de Winter, J P, de Hingh, I H J T, Delis-van Diemen, P M, Tijssen, M, Rooimans, M A, Krijgsman, O, Carvalho, B, Peters, G J, Bonjer, H J, Meijer, G A, te Velde, E A
Publicado 2015

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer

por de Cuba, E. M. V., de Hingh, I. H. J. T., Sluiter, N. R., Kwakman, R., Coupé, V. M. H., Beliën, J. A. M., Verwaal, V. J., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Bonjer, H. J., Meijer, G. A., te Velde, E. A.
Publicado 2016

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy

por Ubink, I., Bolhaqueiro, A. C. F., Elias, S. G., Raats, D. A. E., Constantinides, A., Peters, N. A., Wassenaar, E. C. E., de Hingh, I. H. J. T, Rovers, K. P., van Grevenstein, W. M. U., Laclé, M. M., Kops, G. J. P. L., Borel Rinkes, I. H. M., Kranenburg, O.
Publicado 2019

Completion pancreatectomy or a pancreas-preserving procedure during relaparotomy for pancreatic fistula after pancreatoduodenectomy: a multicentre cohort study and meta-analysis

por Groen, J V, Smits, F J, Koole, D, Besselink, M G, Busch, O R, den Dulk, M, van Eijck, C H J, Groot Koerkamp, B, van der Harst, E, de Hingh, I H, Karsten, T M, de Meijer, V E, Pranger, B K, Molenaar, I Q, Bonsing, B A, van Santvoort, H C, Mieog, J S D
Publicado 2021

Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Tria...

por Bakkers, C., Rovers, K. P., Rijken, A., Simkens, G. A. A. M., Bonhof, C. S., Nienhuijs, S. W., Burger, J. W. A., Creemers, G. J. M., Brandt-Kerkhof, A. R. M., Tuynman, J. B., Aalbers, A. G. J., Wiezer, M. J., de Reuver, P. R., van Grevenstein, W. M. U., Hemmer, P. H. J., Punt, C. J. A., Tanis, P. J., Mols, F., de Hingh, I. H. J. T.
Publicado 2023

Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial

por Engbersen, M. P., Rijsemus, C. J. V., Nederend, J., Aalbers, A. G. J., de Hingh, I. H. J. T., Retel, V., Lambregts, D. M. J., Van der Hoeven, E. J. R. J., Boerma, D., Wiezer, M. J., De Vries, M., Madsen, E. V. E., Brandt-Kerkhof, A. R. M., Van Koeverden, S., De Reuver, P. R., Beets-Tan, R. G. H., Kok, N. F. M., Lahaye, M. J.
Publicado 2021

Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2...

por Janssen, Q. P., van Dam, J. L., Bonsing, B. A., Bos, H., Bosscha, K. P., Coene, P. P. L. O., van Eijck, C. H. J., de Hingh, I. H. J. T., Karsten, T. M., van der Kolk, M. B., Patijn, G. A., Liem, M. S. L., van Santvoort, H. C., Loosveld, O. J. L., de Vos-Geelen, J., Zonderhuis, B. M., Homs, M. Y. V., van Tienhoven, G., Besselink, M. G., Wilmink, J. W., Groot Koerkamp, B.
Publicado 2021